ArticleBMC nephrology2025
Association of platelet trajectory patterns with in-hospital mortality in critically ill adults with acute kidney injury receiving continuous renal replacement therapy.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Persistent Severe Acute Kidney Injury Among Critically Ill Patients: Outcomes and Predictive Markers-A Single-Center Retrospective Cohort Study.Critical care research and practice · 2026Article
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
Abstract
backgroundThrombocytopenia commonly occurs in critically ill patients with acute kidney injury (AKI) receiving continuous renal replacement therapy (CRRT) and is associated with poor outcomes. While previous studies have examined static platelet counts and relative declines, the prognostic significance of platelet trajectory patterns before and after CRRT initiation remains unclear. This study investigates the association between platelet count trajectories and in-hospital mortality in critically ill adult patients with AKI receiving CRRT.
methodsThis study is a single-center retrospective cohort study utilizing electronic health record (EHR) data from critically ill adults (≥ 18 years) with AKI who received CRRT at the University of Alabama at Birmingham between January 2012 and December 2023. Platelet trajectories were assessed using mixed-effects models incorporating all platelet measurements within seven days before and after CRRT initiation. The slopes of platelet count change were categorized as descending (≤ -10 × 10³/µL/day), stable (-10 to 10), or ascending (≥ 10), creating a total of nine trajectory patterns by combining the three pre-CRRT and three during-CRRT categories. The primary outcome was in-hospital mortality, which was analyzed in relation to these trajectory patterns using logistic regression models adjusted for demographics, comorbidities, Sequential Organ Failure Assessment (SOFA) score, medications, and use of other organ support devices as covariates.
resultsThe study included 2,226 critically ill adults with AKI on CRRT, encompassing 8,569 patient-days before and 11,699 patient-days after CRRT initiation for platelet slope calculation. The median age was 59 years (IQR 48–69) and the median SOFA score at CRRT initiation was 12 (9–14). The in-hospital mortality rate was 57.8%. Before CRRT initiation, the most common trajectory was descending (46.2%), while after CRRT initiation, the stable pattern was most prevalent (58.3%). All patterns with a descending platelet trajectory during-CRRT were significantly associated with higher in-hospital mortality (aOR 1.92 [95% CI: 1.16–3.21] for ascending-descending; 1.49 [1.07–2.08] for stable-descending; 1.52 [1.04–2.23] for descending-descending). In contrast, all patterns with stable or increasing platelet counts during-CRRT tended to have lower mortality.
conclusionsA descending platelet trajectory after CRRT initiation was independently associated with increased in-hospital mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.